Adjuvant imatinib for GIST: duration likely matters
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference10 articles.
1. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival;DeMatteo;Ann Surg,2000
2. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor;Joensuu;N Engl J Med,2001
3. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002
4. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
5. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumor: a randomised, double-blind, placebo-controlled trial;Dematteo;Lancet,2009
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term survival outcomes of endoscopic therapy vs. surgical resection in patients with cardia gastrointestinal stromal tumor;PLOS ONE;2024-07-05
2. Synthesis and characterization of a composite incorporating metal organic frameworks, copper oxide nanoparticles, and graphene oxide and evaluating its multifaceted potential in photocatalysis and electrochemical sensing;Journal of Materials Science: Materials in Electronics;2024-07
3. The impact of gender on survival outcomes in patients with small intestinal stromal tumors: a comprehensive analysis using the SEER database;Surgical Endoscopy;2024-06-03
4. Imatinib-induced ulcerative colitis;Journal of Oncology Pharmacy Practice;2024-05-21
5. ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis;Open Medicine;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3